P2D Bioscience
Founded 2005
3 employees
Get notified when P2D Bioscience moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track P2D Bioscience
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksAbout P2D Bioscience
No funding data available for P2D Bioscience yet.
Get notified when P2D Bioscience raises fundingP2D Bioscience Alternatives & Competitors
P2D Bioscience vs
The NeuroCognitive and Behavioral Institute
United States
Integrating Science with Practice
47 employees
Health Care
P2D Bioscience vs
Astrocyte Pharmaceuticals
United States
A Novel Approach to Neuroprotection
Series B
12 employees
Biotechnology, Health and Wellness
P2D Bioscience vs
Annovis Bio, Inc.
United States
Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.
IPO
12 employees
Biotechnology, Health and Wellness
FAQ About P2D Bioscience
P2D Bioscience (P2D) is a specialty pharmaceutical company focused on developing innovative drugs that fulfill unmet medical needs in the treatment of central nervous system (CNS) and pulmonary disorders including attention deficit/hyperactivity disorder (ADHD), obesity, anxiety, depression, Alzheim...
P2D Bioscience was founded in 2005.
P2D Bioscience has approximately 3 employees.
Top alternatives and competitors to P2D Bioscience include The NeuroCognitive and Behavioral Institute, Astrocyte Pharmaceuticals, Annovis Bio, Inc., NeuroScios GmbH, BrainCells. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
P2D Bioscience and The NeuroCognitive and Behavioral Institute are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors P2D Bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.